Press Release

Nov, 18 2022

DaVita Inc., Sunway Med Lab, and Abbott dominated the Malaysia Clinical Laboratory Services Market in 2020

Malaysia Clinical Laboratory Services Market is expected to grow with a CAGR of 5.8% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below.

Access Full Report @

Malaysia clinical laboratory services market is a highly consolidated market, including a specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenarios.    

The major players dealing in the Malaysia clinical laboratory services market are introducing a strong range of product providers, launching new products, and adopting strategic initiatives such as mergers, partnerships, and agreements. This helped companies to maximize sales with an enhanced product portfolio.

For instance,

  • In September 2018, DaVita Kidney Care, a subsidiary of DaVita Inc., a leading provider of kidney care services, expanded its business at 150,000 square-foot facilities of DaVita Laboratories, a clinical laboratory servicing the DaVita dialysis clinics. This expansion will increase the market value of the company

DaVita Inc. is the dominating player in the Malaysia clinical laboratory services market. The other key players in the market include Abbott, Eurofins Scientific, Siemens Healthcare GmbH, Charles River Laboratories, Laboratory Corporation of America Holdings, Syneos Health, Sunway Med lab, PT Kimia Farma Diagnostika, and SGS SA, among others.

Malaysia Clinical Laboratory Services Market,  By DevelopmentsDaVita Inc.

DaVita Inc. has headquarters in Colorado, U.S. It has public ownership. The company focuses on elevating the health and quality of life of patients worldwide and continues to expand operations to improve access to health care. The company has various business segments such as U.S. Dialysis and Other Ancillary Services under which Other Ancillary Services is the market-focused segment. The company has service categories such as education, diet, nutrition, treatment and services, tools. The market-focused category is treatment and services.

For instance,

  • In May 2021, DaVita Inc.’s Kidney Care segment announced the expansion of its home kidney care program, including the HomeChoice Claria Automated Peritoneal Dialysis (APD) system. The remote patient monitoring system Sharesource enables this from Baxter International Inc., a global innovator company in renal care. This expansion has helped the company in extending the automated services in the dialysis system services

The company has a wide presence across North America, Europe, Asia-Pacific, South America, the Middle East, and Africa. The company has various subsidiaries such as Astro, Hobby, West Mt. Renal Care (Germany), Austin Dialysis Centers, L.P. (Germany), Bay Area Dialysis (Liechtenstein), Beverly Hills Dialysis (Canada), Bear Creek Dialysis, L.P (Germany) among others.

Sunway Med Lab

Sunway Med Lab is headquartered in Selangor, Malaysia, and was founded in 1999. It has private ownership. The company offers clinical, molecular and pathology laboratory tests. It plays a critical role in prevention, diagnosing, monitoring, and treating a broad range of conditions, including cancer, chronic diseases, and infectious diseases. The company has business segments such as Hospital and Health Care which are also the market-focused segments. Clinical Laboratory Services, Molecular Diagnostic Laboratory Services, Microbiology Laboratory Services, and Anatomical Pathology Laboratory Services are the company’s service categories and the market-focused categories.

 The company has a presence across Asia-Pacific. The company has initiated many strategic initiatives to expand its market.


Abbott was founded in the year 1888, and it has headquarters in Illinois, U.S. It has public ownership. The company engaged in creating breakthrough products– in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals– that help the community lead healthier lives and make a lasting impact on health. The company has business segments such as Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices under which Diagnostic Products are the market-focused segment. Core Laboratory, Molecular, Point of Care, and Rapid Diagnostics are the company's product categories under which Rapid Diagnostics is the market-focused category.

For instance,

  • In June 2021, Abbott announced it had received CE Mark and Health Canada approval for its Amplatzer Steerable Delivery Sheath, which is used with its market-leading Amplatzer Amulet Left Atrial Appendage (LAA) Occluder. Abbott's Amplatzer Amulet has long been the LAA occlusion device of choice in Europe and Canada to reduce the risk of stroke and eliminate the need for blood-thinning medication in patients with atrial fibrillation. This innovation advances the performance of companies Amplatzer Amulet device and offers patients a much-needed treatment option to help manage stroke risk from atrial fibrillation

The company has a wide presence across North America, South America, Europe, Asia-Pacific, Middle East, and South Africa. The company has various subsidiaries like Abbott Administration Inc(Delaware), Abbott Cardiovascular Systems Inc.(California), Abbott Home Infusion Services of New York, Inc.(New York), Abbott Laboratories (Puerto Rico) Incorporated, EAS Australia Pty Ltd(Australia), Abbott (Cambodia) LLC, Abbott Laboratories A/S(Denmark) among others.

Client Testimonials